CeraVe

CeraVe was developed in 2005 by dermatologists in partnership with what was then Valeant Pharmaceuticals, specifically to create affordable skincare centered on barrier repair. The brand's defining innovation is MVE (MultiVesicular Emulsion) technology, a patented delivery system that encapsulates ceramides and other actives in layered spheres, releasing them gradually over 24 hours rather than depositing everything at once. This slow-release mechanism means a single application continues working long after it dries. L'Oreal acquired CeraVe in 2017 for approximately $1.3 billion, recognizing its explosive growth driven by dermatologist recommendations and social media endorsements. Every CeraVe product contains three essential ceramides (NP, AP, and EOP) that mirror the lipids naturally found in human skin. This consistent ceramide backbone across the entire range -- from cleansers to moisturizers to sunscreens -- means every step of a CeraVe routine contributes to barrier repair. The brand has become the default first recommendation from dermatologists for patients with dry, sensitive, and eczema-prone skin, and its National Eczema Association acceptance on multiple products reinforces its clinical credibility.